LEFLUNOMIDE (has an active metabolite) 
| LEFLUNOMIDE | ATC L04AA13
IMMUNOMODULATIONG AGENT PYRIMIDINE SYNTHESIS INHIBITOR TREATMENT OF PATIENTS WITH RELAPSING FORMS OF MULTIPLE SCLEROSIS ANTIINFLAMMATORY | ORAL | | DIHYDROOROTATE DEHYDROGENASE | DIHYDROOROTATE DEHYDROGENASE INHIBITOR CHEMBL1966 DIHYDROOROTATE DEHYDROGENASE Q02127 DIHYDROOROTATE DEHYDROGENASE (QUINONE), MITOCHONDRIAL HOMO SAPIENS ENZYME REDUCTASE | ANSM (in French) Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |
TERIFLUNOMIDE (is an active metabolite) 
| TERIFLUNOMIDE | ATC L04AA13 ATC L04AA31
IMMUNOMODULATIONG AGENT PYRIMIDINE SYNTHESIS INHIBITOR TREATMENT OF PATIENTS WITH RELAPSING FORMS OF MULTIPLE SCLEROSIS ANTIINFLAMMATORY | ORAL | Cmax 233.3 MICROMOLAR Tmax 9 HOUR F 80 PERCENT VD 11 LITER PPB 99 PERCENT Cl 0.0305 LITER / HOUR HT 456 HOUR SOLUBILITY PRACTICALLY INSOLUBLE IN WATER | DIHYDROOROTATE DEHYDROGENASE PDB 1TV5 (PLASMODIUM FALCIPARUM DIHYDROOROTATE DEHYDROGENASE WITH A BOUND INHIBITOR) LIGAND CODE = A26 (link to the list of PDB complexes) Download experimental 3D coordinates of A26 with added hydrogens | DIHYDROOROTATE DEHYDROGENASE INHIBITOR CHEMBL1966 DIHYDROOROTATE DEHYDROGENASE Q02127 DIHYDROOROTATE DEHYDROGENASE (QUINONE), MITOCHONDRIAL HOMO SAPIENS ENZYME REDUCTASE | ANSM (in French) Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |